NCT06998537

Brief Summary

There is frequent use of alpha blockers in elderly patients with urological disorders. Various side effects are encountered due to the use of alpha blockers in the elderly age group. Especially hypotension is one of the common side effects. In addition, urological surgery is frequently performed in this age group. Spinal anesthesia is the most preferred anesthesia method in urological surgery. Spinal anesthesia may cause significant vasodilatation and thus hemodynamic changes such as hypotension by causing sympathetic nerve blockade. It is predicted that spinal anesthesia may increase these effects especially in individuals using α-1 adrenergic blockers. In the literature, serious hypotension has been encountered in individuals using alpha blockers under general anesthesia. The aim of this study was to compare the intraoperative hemodynamic changes in patients undergoing elective urologic surgery under spinal anesthesia between α-1 adrenergic blocker users (Group 1) and non-users(Group 2). Patients were divided into two groups according to drug use: Group 1: α-1 adrenergic blocker users (alfuzosin, doxazosin, terazosin,silodosin, tamsulosin), Group 2: No α-1 adrenergic blockers.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 22, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 31, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

August 30, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2025

Completed
Last Updated

August 20, 2025

Status Verified

July 1, 2025

Enrollment Period

1 month

First QC Date

May 22, 2025

Last Update Submit

August 19, 2025

Conditions

Keywords

spinal anesthesiaadrenergic α1-receptor antagonists,Urologic Surgical Procedures

Outcome Measures

Primary Outcomes (1)

  • Preop,15 minute,30minute mean arteriyal pressure

    Hypotension MBP \< 50 mmHg

    During procedure (From the beginning to the end of anesthesia)

Secondary Outcomes (1)

  • Preoperative, 15th and 30th minute heart rate

    During procedure (From the beginning to the end of anesthesia)

Study Arms (2)

Group 1: α-1 adrenergic blocker users

Group 2: No α-1 adrenergic blockers.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients scheduled for elective urologic surgery under spinal anesthesia

You may qualify if:

  • Patients with American Society of Anesthesiologists (ASA) physical status classification I,II or III over 18 years of age scheduled for elective urologic surgery under spinal anesthesia

You may not qualify if:

  • Patients not undergoing spinal anesthesia, non-alpha-blocker vasoactive drug users, patients with cardiac disease, medical/surgical history of brain or spinal cord, neurological or psychiatric disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

İzmir City Hospital

Izmir, Bayraklı, 35000, Turkey (Türkiye)

Location

Central Study Contacts

Tuba Kuvvet Yoldas, MD

CONTACT

Mehmet Yoldas, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD,Specialist

Study Record Dates

First Submitted

May 22, 2025

First Posted

May 31, 2025

Study Start

August 30, 2025

Primary Completion

September 30, 2025

Study Completion

October 30, 2025

Last Updated

August 20, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations